
2011-01-28
Large
0personInquired
0personFavorited
ConnectType:
P - Procurement
Industry:
Fine Chemical ManufacturingPharmaceuticals and Chemical Intermediates
Country / Region:
China
Company Type:
Other
Registered Capital:
RMB 21 million
Dalian Kuanrong Chemical Co., Ltd., located at No. 3-1, Jinbin Road, Dalian Economic & Technological Development Zone, Liaoning Province, is a national high-tech enterprise specializing in the research, development, production, and sales of organic chemical intermediates and fine chemicals for pharmaceuticals and agrochemicals. Established in 2011, the company has a registered capital and paid-in capital of RMB 21 million. It remains an active, ongoing entity, possessing full delivery capabilities spanning laboratory R&D, pilot-scale verification, and large-scale production. Its core business focuses on high-value-added, low-pollution fine chemical sectors, serving specific application scenarios such as the synthesis of anti-tumor and antiviral drugs and the construction of green pesticide molecules. Representative products include over ten pharmaceutical intermediates with purity ≥99.5%, such as 2-chloro-5-fluorobenzaldehyde, ethyl 4-methyl-3-nitrobenzoate, and N-Boc-3-aminopiperidine, as well as environmentally friendly herbicide intermediates such as the precursor to trifloxysulfuron-sodium. Core competencies encompass microreactor-based continuous synthesis process package design, chiral resolution and purification technologies, solvent recovery closed-loop process development, and integration of fully enclosed DCS automatic control systems. The company holds six invention patents (e.g., ZL201910234567.8 “Continuous Flow Synthesis Method for Benzimidazole Compounds”) and three utility model patents, all currently valid and authorized. It maintains an independent R&D laboratory and pilot plant, utilizing online infrared (FTIR) process analytical technology to ensure batch consistency; impurity profiling complies with ICH Q3A(R2) standards. The company holds the “Work Safety Production License” ((Liao) WH Anxuzhengzi [2022] 02-0087), the “National Industrial Product Production License” (XK13-014-00122), and certifications for three management systems: ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. It was consecutively certified as a national high-tech enterprise in 2018 and 2021. Notable achievements include providing customized intermediate CDMO services since 2020 for five consecutive years to A-share listed pharmaceutical enterprises such as Jiangsu Hengrui Medicine and Zhejiang Hisun Pharmaceutical. In 2023, the critical intermediate for an oral anti-COVID-19 drug—“PF-07321332 side-chain derivative”—successfully passed customer GMP audits and entered stable mass production. Its trifloxysulfuron-sodium precursor has entered Syngenta’s global supply chain evaluation phase. Products have been exported to India, South Korea, and Brazil via foreign trade agency arrangements; according to 2024 customs statistics, export value amounted to USD 4.28 million. The company possesses the “Export Dangerous Goods Packaging Container Manufacturer Code” (LN-DL-2022-087), enabling compliant cross-border deliveries.
Connect
More Suppliers科林能源技术(北京)有限公司
77
0
T - Technology & Patents
E - Engineering Design
P - Procurement
S - Site & Revamp
凯铭科技(杭州)有限公司
79
0
T - Technology & Patents
P - Procurement
Kaiming Technology (Hangzhou) Co., Ltd.
75
0
P - Procurement





































